What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Robert Wesley mainly focuses on Internal medicine, Immunology, Chemotherapy, Surgery and Randomized controlled trial.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.
His Immunology study combines topics from a wide range of disciplines, such as Beck Depression Inventory and Depression.
The various areas that Robert Wesley examines in his Chemotherapy study include Cancer, Radiation therapy, Soft tissue and Sarcoma.
His Surgery study combines topics from a wide range of disciplines, such as Dermatomyositis, Albumin, Apheresis and Plasmapheresis.
As a part of the same scientific study, Robert Wesley usually deals with the Randomized controlled trial, concentrating on Amputation and frequently concerns with Wide local excision, Cumulative dose, Randomization and Prospective cohort study.
His most cited work include:
- The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. (995 citations)
- The cardiovascular response of normal humans to the administration of endotoxin (964 citations)
- Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition (718 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Surgery, Endocrinology, Immunology and Gastroenterology.
His Internal medicine research includes elements of Oncology and Pathology.
Robert Wesley combines topics linked to Sarcoma with his work on Surgery.
His research investigates the connection between Immunology and topics such as Neonatal onset multisystem inflammatory disease that intersect with problems in Canakinumab.
His Gastroenterology study combines topics in areas such as HBsAg, Hepatitis B virus, Parenteral nutrition, Resuscitation and Fibrosis.
His research in Chemotherapy tackles topics such as Regimen which are related to areas like Anesthesia.
He most often published in these fields:
- Internal medicine (50.85%)
- Surgery (24.86%)
- Endocrinology (22.03%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (50.85%)
- Endocrinology (22.03%)
- Pheochromocytoma (7.91%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Endocrinology, Pheochromocytoma, Paraganglioma and SDHB.
His Internal medicine research is multidisciplinary, incorporating perspectives in Surgery and Pediatrics.
His research in Surgery intersects with topics in Adverse effect and Cryopyrin-associated periodic syndrome.
His study on Lipoprotein, Adrenocorticotropic hormone and Adrenal insufficiency is often connected to Transcortin as part of broader study in Endocrinology.
Robert Wesley focuses mostly in the field of Paraganglioma, narrowing it down to topics relating to Retrospective cohort study and, in certain cases, Blood pressure, Young adult, Cohort study and Odds ratio.
The study incorporates disciplines such as SDHD, Primary tumor, Metastasis and Oncology in addition to SDHB.
Between 2012 and 2021, his most popular works were:
- Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production (156 citations)
- Capillary versus venous haemoglobin determination in the assessment of healthy blood donors. (46 citations)
- A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease (38 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His main research concerns Internal medicine, Surgery, Paraganglioma, SDHB and Pheochromocytoma.
His Internal medicine study frequently draws parallels with other fields, such as Endocrinology.
His research integrates issues of Biomarker and Intravascular large B-cell lymphoma in his study of Endocrinology.
The concepts of his Surgery study are interwoven with issues in Canakinumab and Cryopyrin-associated periodic syndrome.
His Paraganglioma study also includes
- Oncology which connect with Retrospective cohort study, Metastasis, Survival analysis and Penetrance,
- Primary tumor which connect with Asymptomatic and Gene mutation.
His studies deal with areas such as Normetanephrine and Urology as well as SDHB.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
